Claims for Patent: 9,662,396
✉ Email this page to a colleague
Summary for Patent: 9,662,396
Title: | Stable aqueous formulations of etanercept |
Abstract: | The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same. |
Inventor(s): | Manning; Mark (Johnstown, CO), Murphy; Brian (Fort Collins, CO) |
Assignee: | Coherus Biosciences, Inc. (Redwood City, CA) |
Application Number: | 14/592,654 |
Patent Claims: | 1. A stabilized aqueous pharmaceutical composition having long term storage stability, comprising: etanercept and a stabilizer to inhibit instability, aggregation and/or
fragmentation of the etanercept, wherein the composition is free of arginine as a stabilizer and wherein the stabilizer is 1 mM to 20 mM magnesium chloride.
2. The stabilized composition of claim 1 characterized by: (a) an SEC (size exclusion chromatography) analysis at T.sub.4 of greater than 90, 91, 92, 93, 94, 95, 96, or 97 wt. % monomer content; and less than 3, 2 or 1 wt. % aggregate(s) content; and (b) an HIC (hydrophobic interaction chromatography) analysis at T.sub.2 wherein the amount of the composition represented by peak 1 of the HIC chromatogram is less than 3, 2 or 1 wt. %; the amount of the composition represented by peak 2 of the HIC chromatogram is greater than 80, 81, 82, 83, 84 or 85 wt. %; and the amount of the composition represented by peak 3 of the HIC chromatogram is less than 20, 19, 18, 17, 16, 15, 14, or 13 wt. %; and (c) an HIC analysis at T.sub.4 wherein the amount of the composition represented by peak 1 of the HIC chromatogram is less than 3, 2 or 1 wt. %; the amount of the composition represented by peak 2 of the HIC chromatogram is greater than 80, 81, 82, 83, 84 or 85 wt. %; and the amount of the composition represented by peak 3 of the HIC chromatogram is less than 20, 19, 18, 17, 16, 15, 14 or 13 wt. %. 3. The stabilized composition of claim 2 having an HIC analysis at T.sub.4 or T.sub.2 wherein the amount of the composition represented by peak 1 of the HIC chromatogram is less than 2 wt. %; the amount of the composition represented by peak 2 of the HIC chromatogram is greater than 85 wt. %; and the amount of the composition represented by peak 3 of the HIC chromatogram is less than 13 wt. %. 4. The stabilized composition of claim 1 wherein the composition comprises 25 to 50 mg/ml of etanercept; optionally up to 6 wt. % sucrose; 25 to 150 mM NaCl; and 1 to 30 mM sodium phosphate and wherein the composition has a pH of 6.0 to pH 7.0. |
Details for Patent 9,662,396
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2039-02-26 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2039-02-26 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2039-02-26 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 02/01/2007 | ⤷ Try a Trial | 2039-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.